$ELVN
Enliven Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ELVN up today? It is at $60.13 (+0.71%), and our scanner flagged it 81 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ELVN spikes, and full due diligence on ELVN — key stats, earnings, dilution and insider activity. Free.
Get free $ELVN alerts the moment volume spikes
Our scanner flagged $ELVN 81 times in the last 30 days. Create a free account to track $ELVN, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $60.13
- Change today
- +0.71%
- Previous close
- $59.70
- 52-week range
- $14.79 – $62.32
- Market cap
- $3.64B
- Institutional own.
- 94.48%
- Total held
- 97.1%
- Tradeable float
- 2.1M 3% of shares · after 3% insiders + 94% institutions
- Short interest
- 8.7M ▲ +1% vs prior · as of 2026-07-15
- Days to cover
- 9.4d
- Avg daily volume
- 998K
- Next earnings
- Aug 12 · in 6d
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.2x
- 15m
- 0.3x
- 1h
- 0.6x
- 1D
- 0.1x
Get free ELVN + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ELVN up today?
ELVN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ELVN today. Fresh from the SEC: Enliven Therapeutics, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders selling0 buys, 9 sells last 3 months (4/48 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Collins Helen Louise Officer | Sold (automatic/other) | -5K | sold 17% | 25K | $250K at $50.05 | Jul 17, 26 |
Collins Helen Louise Officer | Other | 5K | added 20% | 30K | $12K at $2.48 | Jul 17, 26 |
Hohl Benjamin Officer | Sold (automatic/other) | -6K | sold 12% | 46K | $301K at $49.97 | Jul 17, 26 |
Hohl Benjamin Officer | Other | 1K | added 2.1% | 52K | $3K at $2.48 | Jul 17, 26 |
Kunkel Lori Anne Director | Sold (automatic/other) | -10K 0.02% of company | sold 19% | 42K | $500K at $49.98 | Jul 6, 26 |
Orbimed Advisors Llc Beneficial Owner (10%) | Sold (automatic/other) | -860K 1.4% of company | sold 11% | 6.77M | $38.7M at $45.00 | Jun 22, 26 |
Collins Helen Louise Officer | Sold (automatic/other) | -5K | sold 17% | 25K | $214K at $42.83 | Jun 17, 26 |
Collins Helen Louise Officer | Other | 5K | added 20% | 30K | $12K at $2.48 | Jun 17, 26 |
Hohl Benjamin Officer | Sold (automatic/other) | -6K | sold 11% | 51K | $257K at $42.78 | Jun 17, 26 |
Hohl Benjamin Officer | Other | 6K | added 12% | 57K | $15K at $2.48 | Jun 17, 26 |
Orbimed Advisors Llc Beneficial Owner (10%) | Sold (automatic/other) | -281K 0.5% of company | sold 3.6% | 7.63M | $12.7M at $45.02 | Jun 15, 26 |
Kunkel Lori Anne Director | Sold (automatic/other) | -10K 0.02% of company | sold 16% | 52K | $343K at $34.28 | Jun 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $ELVN runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ELVN Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ELVN Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to ELVN
Comparable names in pharmaceutical preparations, closest in size first.
ELVN stock FAQ
Why is $ELVN up today?
ELVN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ELVN today. Fresh from the SEC: Enliven Therapeutics, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
What is the ELVN stock price today?
ELVN last traded at $60.13, up 0.71% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does ELVN report earnings?
Enliven Therapeutics, Inc. Common Stock (ELVN) is next expected to report earnings on Wednesday, August 12, 2026, about 6 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live ELVN alerts?
The ELVN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ELVN 81 times in the last 30 days.
What exchange is ELVN on?
ELVN (Enliven Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $3.64B in the PHARMACEUTICAL PREPARATIONS sector.
Is ELVN good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ELVN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.